Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: Blue On Black who wrote (917)	1/31/1998 10:24:00 PM
From: Frank Brisebois	Respond to of 3580

Lee: Went to Zacks to see what is up on GERN, and here is what they think: For the LONG's, think they have a very, very long wait.... Don't forget GERN is still in the devolopement stage, and it takes years for FDA Phase i, ii, iii trials to run through. Frank Company Reports:GERON CORP Wall Street Recommendations Number of Brokers Recommending # Strong Buy 2 # Moderate Buy 0 # Hold 0 # Moderate Sell 0 # Strong Sell 0 Current Average Recommendation (1.0=Str. Buy, 5.0=Str. Sell) 1.0 Last Week's Average Recommendation 1.0 Change in Average Recommendation 0.0 Company Industry Group MED-BIOMED/GENE Rank Within Industry 6 of 122 Research Analyst's Earnings Estimates and Actuals Consensus Estimate for Current Fiscal Year ( 12/97 )$ -1.01 per share Consensus Estimate for Next Fiscal Year ( 12/98 ) $ -1.03 per share Consensus Estimate for Current Quarter ( 12/98 ) $ -0.23 per share Actual Earnings Last Quarter ( 9/98 ) $ -0.18 per share EPS Surprise Last Quarter na % Free Company Report was last updated 01/26/98.